HHS proposes nixing Trump rule tying drug costs to foreign rates

Bloomberg

7 August 2021 - Issue previously raised in Trump administration.

The Health and Human Services Department on Friday proposed to withdraw a Trump-era drug payment model tying U.S. costs to foreign prices.

The agency didn’t rule out releasing its own policy for cutting down skyrocketing medicine costs.

Read Bloomberg Law article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing